⚡ Flash Summary

Liven Pharma Limited received Rs. 34,787,800 from directors and substantial shareholders Atif Hussain Siddique and Kashif Hussain Siddique for the proposed right issue of shares. The subscription money was received in Meezan Bank Limited. Auditor Reanda Haroon Zakaria Aamir Salman Rizwan & Company has certified the receipt of these funds. The right issue was approved by the Board of Directors on September 12, 2025.

📌 Key Takeaways

• ✅ Liven Pharma received Rs. 34,787,800 for right issue subscription.
• 👨‍💼 Funds received from directors and substantial shareholders.
• 🏦 Money deposited in Meezan Bank Limited account.
• 🗓️ Receipt certified by Reanda Haroon Zakaria Aamir Salman Rizwan & Company on November 26, 2025.
• 📜 Board of Directors approved the right issue on September 12, 2025.
• 👥 Atif Hussain Siddique subscribed Rs. 17,393,890 for 1,739,389 shares.
• 👥 Kashif Hussain Siddique subscribed Rs. 17,393,910 for 1,739,391 shares.
• ✔️ Auditor verified the bank statements to trace the receipts.
• 🧾 The certificate is for submission to the Pakistan Stock Exchange (PSX).
• 🏢 The company’s management is responsible for compliance with regulations.
• ⚖️ Auditor’s responsibility is limited to verifying the subscription money receipt.
• Shares held by Atif Hussain Siddique before the issue: 40,458,357
• Shares held by Kashif Hussain Siddique before the issue: 40,458,403

🎯 Investment Thesis

HOLD. The announcement indicates a positive development with the successful subscription to the right issue. However, a more comprehensive analysis of the company’s financials is needed to form a stronger investment opinion. The receipt of funds from substantial shareholders is a good sign. Hold until further information releases.